✦ LIBER ✦

A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus

✍ Scribed by R Eisenberg, D Albert, J Stansberry, D Tsai, S Kolasinski, S Khan

Book ID: 120708091
Publisher: BioMed Central
Year: 2003
Tongue: English
Weight: 554 KB
Volume: 5
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar830

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Humanized anti-CD20 monoclonal antibody

Humanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab

✍ Tahir, H. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 72 KB

B cell depletion as a novel treatment fo

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab

✍ R. John Looney; Jennifer H. Anolik; Debbie Campbell; Raymond E. Felgar; Faith Yo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## Objective Safer and more effective therapies are needed for the treatment of systemic lupus erythematosus (SLE). B lymphocytes have been shown to play fundamental pathogenic roles in SLE, and therefore, elimination of B cells with the use of rituximab may represent a new therapy for

Successful treatment of cold agglutinin

Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus

✍ Kotani, T; Takeuchi, T; Kawasaki, Y; Hirano, S; Tabushi, Y; Kagitani, M; Makino, 📂 Article 📅 2006 🏛 SAGE Publications 🌐 English ⚖ 186 KB

Prolonged effects of short-term anti-CD2

Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus

✍ Kai W. Bekar; Teresa Owen; Robert Dunn; Travis Ichikawa; Wensheng Wang; Roger Wa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 796 KB

An open-label safety and efficacy study

An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus

✍ RA Eisenberg, S Khan, J Stansberry, D Tsai, S Kolasinski, E Rieder… 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 391 KB

Treatment of Benign Orbital Pseudolympho

Treatment of Benign Orbital Pseudolymphomas With the Monoclonal Anti-CD20 Antibody Rituximab

✍ Witzig, Thomas E.; Inwards, David J.; Habermann, Thomas M.; Dogan, Ahmet; Kurtin 📂 Article 📅 2007 🏛 Mayo Clinic 🌐 English ⚖ 116 KB